Search General Info
Search Education
Search Partnering Companies

Ryan Muldoon

London, United Kingdom
Ryan Muldoon is the Co-founder and CEO of PrEP Biopharm. He led the spinout of PrEP Biopharm from Janssen securing exclusive worldwide rights to PrEP-001 and ~$30 million of outside investment to develop the compound.

Prior to PrEP Biopharm, he spent 15 years as a commercial executive at Janssen, Forest Laboratories, and Bristol-Myers Squibb. At Janssen his roles included business development and global commercialization within the Infectious Diseases & Vaccines group at Janssen. Prior to Janssen, Muldoon spent time at Bristol-Myers Squibb as the global commercial leader for viral hepatitis, the Country Manager of Sweden, and the US launch leader for HIV compounds. Muldoon has a Masters of International Management from Thunderbird School of Global Management and a BA in German Literature and English from Emory University.
Speaking In
[Available On-Demand]
PrEP Biopharm is a privately held, UK-based, clinical stage biopharma company founded in 2015 as a…